Pharsight

Institut Biochimique patents expiration

1. Tirosint patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7691411 INSTITUT BIOCHIMIQUE Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
Mar, 2024

(15 days ago)

US7723390 INSTITUT BIOCHIMIQUE Pharmaceutical formulations for thyroid hormones
Mar, 2024

(15 days ago)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 13 October, 2006

Treatment: NA

Dosage: CAPSULE;ORAL

How can I launch a generic of TIROSINT before it's drug patent expiration?
More Information on Dosage

TIROSINT family patents

Family Patents

2. Tirosint-sol patents expiration

TIROSINT-SOL's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11096913 INSTITUT BIOCHIMIQUE High-stability packaged solutions of T4 thyroid hormone
Feb, 2037

(12 years from now)

US10537538 INSTITUT BIOCHIMIQUE High-stability packaged solutions of T4 thyroid hormone
Feb, 2037

(12 years from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 15 December, 2016

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of TIROSINT-SOL before it's drug patent expiration?
More Information on Dosage

TIROSINT-SOL family patents

Family Patents